Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque

Acute coronary syndrome (ACS) describes a range of conditions associated with the rupture of high-risk or vulnerable plaque. Vulnerable atherosclerotic plaque is associated with many changes in its microenvironment which could potentially cause rapid plaque progression. Present-day PET imaging prese...

Full description

Bibliographic Details
Main Authors: Benjamin Bartlett, Herbert P. Ludewick, Silvia Lee, Shipra Verma, Roslyn J. Francis, Girish Dwivedi
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/10/2573
_version_ 1827679930552418304
author Benjamin Bartlett
Herbert P. Ludewick
Silvia Lee
Shipra Verma
Roslyn J. Francis
Girish Dwivedi
author_facet Benjamin Bartlett
Herbert P. Ludewick
Silvia Lee
Shipra Verma
Roslyn J. Francis
Girish Dwivedi
author_sort Benjamin Bartlett
collection DOAJ
description Acute coronary syndrome (ACS) describes a range of conditions associated with the rupture of high-risk or vulnerable plaque. Vulnerable atherosclerotic plaque is associated with many changes in its microenvironment which could potentially cause rapid plaque progression. Present-day PET imaging presents a plethora of radiopharmaceuticals designed to image different characteristics throughout plaque progression. Improved knowledge of atherosclerotic disease pathways has facilitated a growing number of pathophysiological targets for more innovative radiotracer design aimed at identifying at-risk vulnerable plaque and earlier intervention opportunity. This paper reviews the efficacy of PET imaging radiotracers <sup>18</sup>F-FDG, <sup>18</sup>F-NaF, <sup>68</sup>Ga-DOTATATE, <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-pentixafor in plaque characterisation and risk assessment, as well as the translational potential of novel radiotracers in animal studies. Finally, we discuss our murine PET imaging experience and the challenges encountered.
first_indexed 2024-03-10T06:39:59Z
format Article
id doaj.art-e76d4b8b6f8f4e42931ff4c117091656
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T06:39:59Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e76d4b8b6f8f4e42931ff4c1170916562023-11-22T17:45:47ZengMDPI AGCells2073-44092021-09-011010257310.3390/cells10102573Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable PlaqueBenjamin Bartlett0Herbert P. Ludewick1Silvia Lee2Shipra Verma3Roslyn J. Francis4Girish Dwivedi5Department of Advanced Clinical and Translational Cardiovascular Imaging, Harry Perkins Institute of Medical Research, Murdoch, WA 6150, AustraliaDepartment of Advanced Clinical and Translational Cardiovascular Imaging, Harry Perkins Institute of Medical Research, Murdoch, WA 6150, AustraliaDepartment of Advanced Clinical and Translational Cardiovascular Imaging, Harry Perkins Institute of Medical Research, Murdoch, WA 6150, AustraliaDepartment of Nuclear Medicine, PET CT and Radionuclide Therapy, Fiona Stanley Hospital, Murdoch, WA 6150, AustraliaSchool of Medicine, University of Western Australia, Perth, WA 6009, AustraliaDepartment of Advanced Clinical and Translational Cardiovascular Imaging, Harry Perkins Institute of Medical Research, Murdoch, WA 6150, AustraliaAcute coronary syndrome (ACS) describes a range of conditions associated with the rupture of high-risk or vulnerable plaque. Vulnerable atherosclerotic plaque is associated with many changes in its microenvironment which could potentially cause rapid plaque progression. Present-day PET imaging presents a plethora of radiopharmaceuticals designed to image different characteristics throughout plaque progression. Improved knowledge of atherosclerotic disease pathways has facilitated a growing number of pathophysiological targets for more innovative radiotracer design aimed at identifying at-risk vulnerable plaque and earlier intervention opportunity. This paper reviews the efficacy of PET imaging radiotracers <sup>18</sup>F-FDG, <sup>18</sup>F-NaF, <sup>68</sup>Ga-DOTATATE, <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-pentixafor in plaque characterisation and risk assessment, as well as the translational potential of novel radiotracers in animal studies. Finally, we discuss our murine PET imaging experience and the challenges encountered.https://www.mdpi.com/2073-4409/10/10/2573PET imagingatherosclerosisvulnerable plaqueinflammation
spellingShingle Benjamin Bartlett
Herbert P. Ludewick
Silvia Lee
Shipra Verma
Roslyn J. Francis
Girish Dwivedi
Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
Cells
PET imaging
atherosclerosis
vulnerable plaque
inflammation
title Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
title_full Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
title_fullStr Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
title_full_unstemmed Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
title_short Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
title_sort imaging inflammation in patients and animals focus on pet imaging the vulnerable plaque
topic PET imaging
atherosclerosis
vulnerable plaque
inflammation
url https://www.mdpi.com/2073-4409/10/10/2573
work_keys_str_mv AT benjaminbartlett imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque
AT herbertpludewick imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque
AT silvialee imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque
AT shipraverma imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque
AT roslynjfrancis imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque
AT girishdwivedi imaginginflammationinpatientsandanimalsfocusonpetimagingthevulnerableplaque